Stay updated on Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page.

Latest updates to the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page
- CheckyesterdayChange DetectedThe page footer now shows Revision: v3.6.2. This indicates a new build/version of the page rather than changes to the study record.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record history adds a note that the study is no longer looking for participants and updates the revision to v3.6.0, replacing the prior v3.5.5 entry.SummaryDifference0.1%

- Check22 days agoChange DetectedThe Record History now shows Revision: v3.5.5 in place of Revision: v3.5.4. This update reflects a new site release/version label rather than changes to the study data or page content.SummaryDifference0.0%

- Check44 days agoChange DetectedA new site revision label 'Revision: v3.5.4' was added to the history while the previous 'Revision: v3.5.3' was removed. This updates the page's revision metadata without altering trial data.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page header updates the ClinicalTrials.gov revision/version indicator from v3.5.2 to v3.5.3, reflecting a platform release rather than a change to the trial history data.SummaryDifference0.0%

- Check72 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page.